+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Companion Diagnostic Market, By Products and Services (Kits and Reagents, Assays, Software, and Services), By Technology, By Disease Indication, By End-User, By Application, By Region, Competition Forecast & Opportunities, 2026

  • ID: 5031335
  • Report
  • October 2021
  • Region: Global
  • 111 pages
  • TechSci Research
UP TO OFF
until Dec 31st 2021
The Global Companion Diagnostic Market is Expected to Reach USD 38.79 Billion by 2026, Growing at Double-Digit CAGR of 11.13% Over the Forecast Period.

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Bayer AG
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • MORE
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Companion Diagnostic Market is expected to reach USD38.79 billion by 2026, growing at double-digit CAGR of 11.13% over the forecast period. The key factor responsible for the growth of companion diagnostic market is the growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2026.

The Global Companion Diagnostic Market is segmented based on products and services, technology, disease indication, end-user, application, company, and region. The market can be segmented into pharmaceutical & biotechnology companies, research laboratories, contract research organization, and others based on end-user. Out of these, the pharmaceutical & biotechnology companies dominated the market in terms of largest market share until 2020 and is further anticipated to be the fastest-growing application segment in the companion diagnostic market during the next five years as well. This growth can be accredited to the widespread use of companion diagnostics in such industries because of their increasing stronghold in the drug development sector as well as the growing importance of companion diagnostic biomarkers. Additionally, surge in requirement for personalized medicines coupled with high demand for targeted therapies for the treatment of multiple diseases and disorders is further boosting the growth of the segment across the globe.

Major players operating in the Global Companion Diagnostic Market include Thermo Fisher Scientific Inc., Illumina Inc., Bayer AG, Quest Diagnostics Inc., Danaher Corporation, Qiagen NV, Seimens Healthineers AG, F. Hoffmann-La Roche AG, Agilent Technologies Inc., Abbott Laboratories Inc., DiaSorin SpA (Luminex Corporation), Icon Plc (MolecularMD Corporation), Myriad Genetics Inc., Biogenex Laboratories Inc., bioMérieux SA and others. The companies operating in the Global Companion Diagnostic Market are focusing on expanding their share in the market. For instance, these key players are making organic strategies such as new product launches & approvals, among others in order to enrich their consumer base.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the Global Companion Diagnostic Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Companion Diagnostic Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Companion Diagnostic Market based on products and services, technology, disease indication, end-user, application, company and region.
  • To identify drivers and challenges for the Global Companion Diagnostic Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Companion Diagnostic Market.
  • To conduct pricing analysis for the Global Companion Diagnostic Market.
  • To identify and analyse the profile of leading players operating in the Global Companion Diagnostic Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of hospitals/clinics across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The publisher analyzed the new products, technologies and presence of all major players across the globe.

The publisher calculated the market size of the Global Companion Diagnostic Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

  • Companion diagnostic hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to companion diagnostic
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Companion Diagnostic Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Companion Diagnostic Market, By Products and Services:

  • Kits and Reagents
  • Assays
  • Software and Services

Global Companion Diagnostic Market, By Technology:

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • In-situ Hybridization
  • Immunohistochemistry
  • Others

Global Companion Diagnostic Market, By Disease Indication:

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Others

Global Companion Diagnostic Market, By End-User:

  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories
  • Contract research organization
  • Others

Global Companion Diagnostic Market, By Application:

  • In-Vitro diagnostics
  • Drug Discovery
  • Others

Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Companion Diagnostic Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.

Please note: With the Enterprise license, the PDF product is printable and editable and comes with a market data excel sheet.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Bayer AG
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • MORE
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Companion Diagnostic Market

4. Executive Summary

5. Voice of Customer
5.1. Factors Driving the Companion Diagnostic Market
5.2. Brand Awareness
5.3. Customer Satisfaction Analysis

6. Global Companion Diagnostic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products and Services (Kits and Reagents, Assays, Software and Services)
6.2.2. By Technology (Polymerase Chain Reaction (PCR), Next-Generation sequencing (NGS), In-Situ Hybridization, Immunohistochemistry and Others)
6.2.3. By Disease Indication (Oncology, Neurology, Cardiology, Infectious Diseases and Others)
6.2.4. By End-User (Pharmaceutical & Biotechnology Companies, Research Laboratories, Contract Research Organization and Others)
6.2.5. By Application (In-Vitro Diagnostics, Drug Discovery and Others)
6.2.6. By Company (2020)
6.2.7. By Region
6.3. Product Market Map

7. North America Companion Diagnostic Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products and Services
7.2.2. By Technology
7.2.3. By Disease Indication
7.2.4. By End User
7.2.5. By Application
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Companion Diagnostic Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products and Services
7.3.1.2.2. By Technology
7.3.1.2.3. By Disease Indication
7.3.1.2.4. By End User
7.3.1.2.5. By Application
7.3.2. Canada Companion Diagnostic Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products and Services
7.3.2.2.2. By Technology
7.3.2.2.3. By Disease Indication
7.3.2.2.4. By End User
7.3.2.2.5. By Application
7.3.3. Mexico Companion Diagnostic Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products and Services
7.3.3.2.2. By Technology
7.3.3.2.3. By Disease Indication
7.3.3.2.4. By End User
7.3.3.2.5. By Application

8. Europe Companion Diagnostic Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products and Services
8.2.2. By Technology
8.2.3. By Disease Indication
8.2.4. By End User
8.2.5. By Application
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Companion Diagnostic Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products and Services
8.3.1.2.2. By Technology
8.3.1.2.3. By Disease Indication
8.3.1.2.4. By End User
8.3.1.2.5. By Application
8.3.2. United Kingdom Companion Diagnostic Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products and Services
8.3.2.2.2. By Technology
8.3.2.2.3. By Disease Indication
8.3.2.2.4. By End User
8.3.2.2.5. By Application
8.3.3. France Companion Diagnostic Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products and Services
8.3.3.2.2. By Technology
8.3.3.2.3. By Disease Indication
8.3.3.2.4. By End User
8.3.3.2.5. By Application
8.3.4. Italy Companion Diagnostic Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products and Services
8.3.4.2.2. By Technology
8.3.4.2.3. By Disease Indication
8.3.4.2.4. By End User
8.3.4.2.5. By Application
8.3.5. Spain Companion Diagnostic Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products and Services
8.3.5.2.2. By Technology
8.3.5.2.3. By Disease Indication
8.3.5.2.4. By End User
8.3.5.2.5. By Application

9. Asia-Pacific Companion Diagnostic Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products and Services
9.2.2. By Technology
9.2.3. By Disease Indication
9.2.4. By End User
9.2.5. By Application
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Companion Diagnostic Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products and Services
9.3.1.2.2. By Technology
9.3.1.2.3. By Disease Indication
9.3.1.2.4. By End User
9.3.1.2.5. By Application
9.3.2. Japan Companion Diagnostic Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products and Services
9.3.2.2.2. By Technology
9.3.2.2.3. By Disease Indication
9.3.2.2.4. By End User
9.3.2.2.5. By Application
9.3.3. India Companion Diagnostic Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products and Services
9.3.3.2.2. By Technology
9.3.3.2.3. By Disease Indication
9.3.3.2.4. By End User
9.3.3.2.5. By Application
9.3.4. South Korea Companion Diagnostic Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Products and Services
9.3.4.2.2. By Technology
9.3.4.2.3. By Disease Indication
9.3.4.2.4. By End User
9.3.4.2.5. By Application
9.3.5. Australia Companion Diagnostic Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Products and Services
9.3.5.2.2. By Technology
9.3.5.2.3. By Disease Indication
9.3.5.2.4. By End User
9.3.5.2.5. By Application
9.3.6. Singapore Companion Diagnostic Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Products and Services
9.3.6.2.2. By Technology
9.3.6.2.3. By Disease Indication
9.3.6.2.4. By End User
9.3.6.2.5. By Application

10. South America Companion Diagnostic Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products and Services
10.2.2. By Technology
10.2.3. By Disease Indication
10.2.4. By End User
10.2.5. By Application
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Companion Diagnostic Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products and Services
10.3.1.2.2. By Technology
10.3.1.2.3. By Disease Indication
10.3.1.2.4. By End User
10.3.1.2.5. By Application
10.3.2. Argentina Companion Diagnostic Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products and Services
10.3.2.2.2. By Technology
10.3.2.2.3. By Disease Indication
10.3.2.2.4. By End User
10.3.2.2.5. By Application
10.3.3. Colombia Companion Diagnostic Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products and Services
10.3.3.2.2. By Technology
10.3.3.2.3. By Disease Indication
10.3.3.2.4. By End User
10.3.3.2.5. By Application

11. Middle East and Africa Companion Diagnostic Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Products and Services
11.2.2. By Technology
11.2.3. By Disease Indication
11.2.4. By End User
11.2.5. By Application
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Companion Diagnostic Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Products and Services
11.3.1.2.2. By Technology
11.3.1.2.3. By Disease Indication
11.3.1.2.4. By End User
11.3.1.2.5. By Application
11.3.2. Saudi Arabia Companion Diagnostic Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Products and Services
11.3.2.2.2. By Technology
11.3.2.2.3. By Disease Indication
11.3.2.2.4. By End User
11.3.2.2.5. By Application
11.3.3. UAE Companion Diagnostic Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Products and Services
11.3.3.2.2. By Technology
11.3.3.2.3. By Disease Indication
11.3.3.2.4. By End User
11.3.3.2.5. By Application

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Thermo Fisher Scientific Inc.
14.2.2. Illumina Inc.
14.2.3. Bayer AG
14.2.4. Quest Diagnostics Inc.
14.2.5. Danaher Corporation
14.2.6. Qiagen NV
14.2.7. Seimens Healthineers AG
14.2.8. F. Hoffmann-La Roche AG
14.2.9. Agilent Technologies Inc.
14.2.10. Abbott Laboratories Inc.
14.2.11. DiaSorin SpA (Luminex Corporation)
14.2.12. Icon Plc (MolecularMD Corporation)
14.2.13. Myriad Genetics Inc.
14.2.14. Biogenex Laboratories Inc.
14.2.15. bioMérieux SA

15. Strategic Recommendations

16. About the Publisher & Disclaimer

List of Figures


Figure 1: Global Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Companion Diagnostic Market Share, By Products and Services, By Value, By Value, 2016-2026F
Figure 3: Global Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 4: Global Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 5: Global Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 6: Global Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 7: Global Companion Diagnostic Market Share, By Company, By Value, 2020
Figure 8: Global Companion Diagnostic Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Companion Diagnostic Product Market Map, By Value, 2016-2026F
Figure 10: North America Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 11: North America Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 12: North America Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 13: North America Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 14: North America Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 15: North America Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 16: North America Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
Figure 17: United States Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 18: United States Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 19: United States Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 20: United States Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 21: United States Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 22: United States Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 23: Canada Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 24: Canada Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 25: Canada Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 26: Canada Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 27: Canada Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 28: Canada Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 29: Mexico Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 30: Mexico Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 31: Mexico Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 32: Mexico Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 33: Mexico Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 34: Mexico Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 35: Europe Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 36: Europe Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 37: Europe Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 38: Europe Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 39: Europe Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 40: Europe Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 41: Europe Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
Figure 42: Germany Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 43: Germany Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 44: Germany Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 45: Germany Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 46: Germany Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 47: Germany Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 48: United Kingdom Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 49: United Kingdom Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 50: United Kingdom Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 51: United Kingdom Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 52: United Kingdom Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 53: United Kingdom Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 54: France Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 55: France Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 56: France Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 57: France Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 58: France Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 59: France Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 60: Italy Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 61: Italy Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 62: Italy Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 63: Italy Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 64: Italy Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 65: Italy Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 66: Spain Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 67: Spain Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 68: Spain Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 69: Spain Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 70: Spain Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 71: Spain Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 72: Asia-Pacific Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 73: Asia-Pacific Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 74: Asia-Pacific Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 75: Asia-Pacific Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 76: Asia-Pacific Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 77: Asia-Pacific Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 78: Asia-Pacific Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
Figure 79: China Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 80: China Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 81: China Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 82: China Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 83: China Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 84: China Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 85: Japan Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 86: Japan Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 87: Japan Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 88: Japan Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 89: Japan Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 90: Japan Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 91: India Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 92: India Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 93: India Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 94: India Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 95: India Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 96: India Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 97: South Korea Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 98: South Korea Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 99: South Korea Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 100: South Korea Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 101: South Korea Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 102: South Korea Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 103: Australia Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Australia Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 105: Australia Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 106: Australia Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 107: Australia Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 108: Australia Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 109: Singapore Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 110: Singapore Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 111: Singapore Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 112: Singapore Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 113: Singapore Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 114: Singapore Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 115: South America Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 116: South America Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 117: South America Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 118: South America Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 119: South America Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 120: South America Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 121: South America Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
Figure 122: Brazil Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 123: Brazil Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 124: Brazil Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 125: Brazil Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 126: Brazil Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 127: Brazil Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 128: Argentina Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 129: Argentina Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 130: Argentina Companion Diagnostic Market Share, By Technology, By Value, 2016-2026
Figure 131: Argentina Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 132: Argentina Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 133: Argentina Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 134: Colombia Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 135: Colombia Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 136: Colombia Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 137: Colombia Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 138: Colombia Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 139: Colombia Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 140: Middle East and Africa Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 141: Middle East and Africa Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 142: Middle East and Africa Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 143: Middle East and Africa Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 144: Middle East and Africa Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 145: Middle East and Africa Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 146: Middle East and Africa Companion Diagnostic Market Share, By Country, By Value, 2016-2026F
Figure 147: South Africa Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 148: South Africa Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 149: South Africa Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 150: South Africa Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 151: South Africa Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 152: South Africa Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 153: Saudi Arabia Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 154: Saudi Arabia Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 155: Saudi Arabia Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 156: Saudi Arabia Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 157: Saudi Arabia Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 158: Saudi Arabia Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Figure 159: UAE Companion Diagnostic Market Size, By Value (USD Billion), 2016-2026F
Figure 160: UAE Companion Diagnostic Market Share, By Products and Services, By Value, 2016-2026F
Figure 161: UAE Companion Diagnostic Market Share, By Technology, By Value, 2016-2026F
Figure 162: UAE Companion Diagnostic Market Share, By Disease Indication, By Value, 2016-2026F
Figure 163: UAE Companion Diagnostic Market Share, By End User, By Value, 2016-2026F
Figure 164: UAE Companion Diagnostic Market Share, By Application, By Value, 2016-2026F
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 1.Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Bayer AG
  • Quest Diagnostics Inc.
  • Danaher Corporation
  • Qiagen NV
  • Seimens Healthineers AG
  • F. Hoffmann-La Roche AG
  • Agilent Technologies Inc.
  • Abbott Laboratories Inc.
  • DiaSorin SpA (Luminex Corporation)
  • Icon Plc (MolecularMD Corporation)
  • Myriad Genetics Inc.
  • Biogenex Laboratories Inc.
  • bioMérieux SA
Note: Product cover images may vary from those shown
Adroll
adroll